This company has been marked as potentially delisted and may not be actively trading. Genesis Healthcare (GEN) Competitors Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsCompetitorsDividendEarningsHeadlinesInsider TradesOptions ChainOwnershipTrendsBuy This Stock GEN vs. CDAY, CCCS, ZI, SVFCX, SEMR, MIXT, XPER, IDN, MAQC, and MTBLYShould you be buying Genesis Healthcare stock or one of its competitors? The main competitors of Genesis Healthcare include Ceridian HCM (CDAY), CCC Intelligent Solutions (CCCS), ZoomInfo Technologies (ZI), Smead Value C (SVFCX), Semrush (SEMR), MiX Telematics (MIXT), Xperi (XPER), Intellicheck (IDN), Maquia Capital Acquisition (MAQC), and Moatable (MTBLY). Genesis Healthcare vs. Its Competitors Ceridian HCM CCC Intelligent Solutions ZoomInfo Technologies Smead Value C Semrush MiX Telematics Xperi Intellicheck Maquia Capital Acquisition Moatable Ceridian HCM (NYSE:CDAY) and Genesis Healthcare (NYSE:GEN) are both prepackaged software industry companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, valuation, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings. Do institutionals & insiders believe in CDAY or GEN? 82.1% of Genesis Healthcare shares are owned by institutional investors. 4.5% of Ceridian HCM shares are owned by company insiders. Comparatively, 3.3% of Genesis Healthcare shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term. Do analysts rate CDAY or GEN? Genesis Healthcare has a consensus target price of $33.25, indicating a potential upside of 15.49%. Given Genesis Healthcare's stronger consensus rating and higher possible upside, analysts plainly believe Genesis Healthcare is more favorable than Ceridian HCM.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ceridian HCM 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Genesis Healthcare 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 Which has stronger valuation & earnings, CDAY or GEN? Genesis Healthcare has higher revenue and earnings than Ceridian HCM. Genesis Healthcare is trading at a lower price-to-earnings ratio than Ceridian HCM, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCeridian HCM$1.45B6.21-$73.40M$0.031,922.33Genesis Healthcare$2.80B6.58$836M$0.9031.99 Is CDAY or GEN more profitable? Genesis Healthcare has a net margin of 17.83% compared to Ceridian HCM's net margin of 0.28%. Genesis Healthcare's return on equity of 155.48% beat Ceridian HCM's return on equity.Company Net Margins Return on Equity Return on Assets Ceridian HCM0.28% 2.03% 0.51% Genesis Healthcare 17.83%155.48%9.12% Which has more volatility & risk, CDAY or GEN? Ceridian HCM has a beta of 1.38, meaning that its share price is 38% more volatile than the S&P 500. Comparatively, Genesis Healthcare has a beta of 0.84, meaning that its share price is 16% less volatile than the S&P 500. Does the media prefer CDAY or GEN? In the previous week, Genesis Healthcare had 2 more articles in the media than Ceridian HCM. MarketBeat recorded 2 mentions for Genesis Healthcare and 0 mentions for Ceridian HCM. Ceridian HCM's average media sentiment score of 0.59 beat Genesis Healthcare's score of 0.00 indicating that Ceridian HCM is being referred to more favorably in the media. Company Overall Sentiment Ceridian HCM Positive Genesis Healthcare Neutral SummaryGenesis Healthcare beats Ceridian HCM on 12 of the 16 factors compared between the two stocks. Get Genesis Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for GEN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding GEN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart GEN vs. The Competition Export to ExcelMetricGenesis HealthcarePrepackaged software IndustryBusiness SectorNYSE ExchangeMarket Cap$18.40B$7.74B$14.77B$20.69BDividend Yield3.05%0.89%2.80%3.67%P/E Ratio31.99153.1024.0529.07Price / Sales6.584.1668.2966.55Price / Cash8.4257.6026.9422.84Price / Book-179.943.945.074.43Net Income$836M$77.43M$195.86M$994.22M Genesis Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)GENGenesis Healthcare1.258 of 5 stars$28.79-2.4%$33.25+15.5%+16.8%$18.40B$2.80B31.992,700CDAYCeridian HCM1.4797 of 5 stars$58.25+1.1%N/A-2.7%$9.09B$1.45B1,942.318,526CCCSCCC Intelligent Solutions3.506 of 5 stars$9.69-0.7%$12.06+24.5%-4.8%$6.39B$969.13M484.742,350Trending NewsEarnings ReportAnalyst ForecastGap UpZIZoomInfo Technologies0.3189 of 5 stars$10.41-0.4%$10.63+2.1%-1.7%$3.56B$1.21B347.123,540News CoveragePositive NewsUpcoming EarningsSVFCXSmead Value CN/A$73.17-0.3%N/AN/A$3.00BN/A0.002SEMRSemrush3.1303 of 5 stars$9.04+1.4%$16.43+81.8%-39.9%$1.34B$396.02M112.981,170MIXTMiX TelematicsN/A$14.55flatN/AN/A$353.75M$150.06M58.201,080XPERXperi3.066 of 5 stars$7.61-0.7%$19.00+149.8%-26.7%$346.16M$488.88M-4.002,100Upcoming EarningsAnalyst ForecastIDNIntellicheck1.2658 of 5 stars$5.46+4.4%$5.83+6.8%+58.6%$108.35M$20.21M-182.0050High Trading VolumeMAQCMaquia Capital AcquisitionN/A$11.30flatN/AN/A$58.99MN/A0.004MTBLYMoatableN/A$1.35+8.0%N/A+130.7%$24.06M$52.07M-13.50410Gap Up Related Companies and Tools Related Companies CDAY Alternatives CCCS Alternatives ZI Alternatives SVFCX Alternatives SEMR Alternatives MIXT Alternatives XPER Alternatives IDN Alternatives MAQC Alternatives MTBLY Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:GEN) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredDigital Dollar Alert: Protect Your Wealth Before It’s Too Late134 countries are developing Central Bank Digital Currencies — and the U.S. is quietly testing one. Experts...American Alternative | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredWhy AMZN, GOOG, MSFT might destroy NVDAInvesting Legend Hints the End May be Near for These 3 Iconic Stocks Futurist Eric Fry say Amazon, Tesla an...InvestorPlace | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Genesis Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Genesis Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
